Featured

In the magazine: Deals of the year – Six of the best exits in 2021; Manufacturing and Industrials – a nine-page special report; ‘Green-it-up’ capital; How to woo blue-collar workers; A keynote interview with Middleground Capital; Plus much more…

TaylorMade was buried in the bunker until KPS made a brilliant sand save.

Accel-KKR saw that Seequent’s geological scanning software could dig much deeper than first thought, with far more applications possible.

Scalpel! Francisco’s carve-out of Capsule Technologies, which provides patient monitoring and medical device integration, was just what the doctor ordered.

We toast the work of six private equity firms for their highly successful deals made in 2021. Francisco Partners takes the top prize with its carve-out of medical device maker Capsule Technologies.

EQT sold Aldevron for $9.6bn just 22 months after buying the maker of mRNA vaccine components for $3.4bn.

Argosy transforms Paragon from niche player in the nuclear power sector to predominant force.

Private Equity International sits down with the Blackstone president and COO to discuss Ukraine, what inflation and rising rates could mean for private equity and the firm's path to $1trn in AUM.

Amid heightened scrutiny over data privacy and disclosure requirements, private equity firms should know the basic housekeeping on compliance, writes Ashurst’s UK data protection head Rhiannon Webster.

In the magazine: How artificial intelligence can open new doors for PE; What the SEC’s private markets plans mean for your cybersecurity; Keynote interviews with Goldman Sachs, Epicor, TMF Group, Bite Investments, Arcesium and BlackRock; Plus much more…